Breaking News

Actavis Appoints Chief Accounting Officer

August 16, 2013

D'Arecca brings extensive industry experience

James D'Arecca has been appointed chief accounting officer at Actavis, Inc. He reports to R. Todd Joyce, global chief financial officer. Mr. D'Arecca joins the company from Bausch & Lomb, where he served in a similar role to his new position at Actavis.
 
Prior to Bausch & Lomb, he served as executive director and business development controller at Merck, where he was the primary liaison between the controller's organization and the business development and corporate licensing functions. Previously, Mr. D'Arecca was executive director and assistant controller at Schering-Plough. He also spent 13 years with PricewaterhouseCoopers, with a focus on pharmaceuticals, medical devices and consumer products.
blog comments powered by Disqus
  • CMO Systems

    CMO Systems

    Philip K. Burns, CRO Consulting||April 5, 2016
    A CMO system includes four aspects of the product lifecycle: regulatory, technical, compliance, and operations.

  • Injectables: The New Oral?

    Injectables: The New Oral?

    Tugrul Kararli, Kurt Sedo, Josef Bossart, PharmaCircle LLC||April 5, 2016
    The growth trend of injectables continues across the pharma landscape.

  • Biopharmaceutical Contract Manufacturing Contract Negotiations

    Biopharmaceutical Contract Manufacturing Contract Negotiations

    William Downey, HighTech Business Decisions||April 5, 2016
    Navigating the complexities of supply agreements.